Skip to main content

CORRECTION article

Front. Pharmacol.
Sec. Pharmacology of Anti-Cancer Drugs
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1433625

Corrigendum: Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction

Provisionally accepted
  • 1 Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India
  • 2 Department of Drug Metabolism and Pharmacokinetics, Zydus Cadila, Ahmadabad, India

The final, formatted version of the article will be published soon.

    Bakrania et al.

    Keywords: DEAE-Dextran, β-Interferon, TNBC, Anti-proliferative, Apoptosis, Angiogenesis, VEGF, NOTCH1

    Received: 16 May 2024; Accepted: 27 Nov 2024.

    Copyright: © 2024 Bakrania, Variya and Patel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Anita K Bakrania, Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India
    Snehal S. Patel, Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.